Earnings calls

Inventurus Knowl concall ledger

Every earnings call for IKS — management tone, guidance, KPIs and promise tracking, quarter by quarter.

IKS · 6 transcripts · Information Technology · latest Q4 FY26

Q4 FY26Published 29 Apr 2026Call held 29 Apr 2026

IKS Q4 FY26 Earnings Call Transcript & Analysis

Combined Revenue698 millionCombined Adjusted EBITDA186 millionPAT Accretion5 millionIKS Revenue CAGR0.28%IKS EBITDA CAGR0.33%

Combined Revenue 698 million; Combined Adjusted EBITDA 186 million; PAT Accretion 5 million. Acquisition of TruBridge for $557 million enterprise value to create an integrated system of record and action.

Read full transcript & analysis

Q3 FY26Published 05 Feb 2026Call held 05 Feb 2026

IKS Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹815 cr+24% YoYEBITDA₹281 cr+40% YoYPAT₹183 cr+41% YoYEPS₹11+40% YoYAdjusted ROE33%

Revenue ₹815 cr (+24% YoY); EBITDA ₹281 cr (+40% YoY); PAT ₹183 cr (+41% YoY). Revenue of ₹815 crores, up 24% YoY (19% in constant currency).

Read full transcript & analysis

Q2 FY26Published 06 Nov 2025Call held 06 Nov 2025

IKS Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹781 cr+22% YoYEBITDA₹272 cr+43% YoYEBITDA Margin35%PAT₹181 cr+60% YoYEPS₹10.8

Revenue ₹781 cr (+22% YoY); EBITDA ₹272 cr (+43% YoY); EBITDA Margin 35%. Revenue grew 22% YoY to INR 781 crores.

Read full transcript & analysis

Q1 FY26Published 01 Aug 2025Call held 01 Aug 2025

IKS Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹740 cr+16% YoYEBITDA Margin32%+36% YoYPAT₹151 cr+59% YoYEPS₹9+58% YoYNet Debt₹448 cr

Revenue ₹740 cr (+16% YoY); EBITDA Margin 32% (+36% YoY); PAT ₹151 cr (+59% YoY). Revenue of ₹740 crores, up 16% YoY (13% constant currency).

Read full transcript & analysis

Q4 FY25Published 03 Jul 2025Call held 03 Jul 2025

IKS Q4 FY25 Earnings Call Transcript & Analysis

Investment in MSO17 millionPre-money Valuation of MSO18.4 millionOwnership in MSO48%MSO Revenue Share63%IKS Platform Revenue Potential10%

Investment in MSO 17 million; Pre-money Valuation of MSO 18.4 million; Ownership in MSO 48%. Strategic investment of $17 million for a 48% stake in Western Washington Medical Group's MSO.

Read full transcript & analysis

Q3 FY25Published 06 Feb 2025Call held 06 Feb 2025

IKS Q3 FY25 Earnings Call Transcript & Analysis

Revenue₹657.2 cr+16% YoYEBITDA₹201 cr+24% YoYEBITDA Margin30.5%PAT₹130 cr+28% YoYEPS₹8

Revenue ₹657 cr (+16% YoY); EBITDA ₹201 cr (+24% YoY); EBITDA Margin 30.5%. Revenue of ₹657.2 crores, up 16% YoY.

Read full transcript & analysis